4
Changes in Ownership
Jasper Therapeutics, Inc. Filed Acc 0001013762-23-003901
Director sold 7,965 shares at $0.85 ($6,777)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Lis William · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-10-13 | Sale : show line 1 in the form 10b5-1 | −7,965 | $0.85 | $6,777 | 53,521 | D |
| Open-market sales · 7,965 sh · avg $0.85 · $6,777 | ||||||
Loading xslF345X05/ownership.xml…